COMPARE · Reviewed August 7, 2026
ADUS vs DVA
Verdict: Side-by-side breakdown using the Bull Rankings model. ADUS scored 75.0, DVA scored 68.4 — ADUS leads.
Compare another set
ADUS
Addus HomeCare Corporation
75
$119.68 · $2.2B
fundamentals as of
Score gap
6.6
ADUS leads
DVA
DaVita Inc.
68.4
$183.77 · $11.7B
fundamentals as of
The model, pillar by pillar (0–100 each)
ADUS
stronger →← stronger
DVA
59
Qualityreturns · margins · balance sheet
69
92
Growthrevenue & earnings expansion
68
79
Valuevaluation vs sector peers
68
ADUS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
ADUS
DVA
$155mC
FCF
$1.6bC+
+15.9%B+
Rev
+6.4%C+
0.09B+
D/E
—
21.0xB+
P/E
15.6xA-
1.09B+
PEG
0.73A-
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
ADUS
DVA
19% below
Price vs fair valuelower is cheaper
66% below
~0%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-16%/yr
+18%
1-yr DCF upside
+153%
+23%
5-yr DCF upside
+198%
+32%
10-yr DCF upside
+278%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ADUS
No notable signals flagged.
DVA
Why this score
- Buying back stock
- Durable high returns
The companies
ADUSAddus HomeCare Corporation
Why now
Medical Care Facilities · market cap $2.2b. 4% off the 52-week high of $124.44. Revenue growing +16%, comfortably above the S&P median. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $134.31 (implying +12% upside).
Moat
FCF converts 147% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
DVADaVita Inc.
Why now
Medical Care Facilities · market cap $11.7b. Down 26% from 52-week high of $247.49 — deep drawdown territory. PEG 0.73 — paying under fair value for the growth rate. 7 sell-side analysts publish a mean 1-yr target of $208.57 (implying +13% upside).
Moat
FCF converts 136% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
ROE -154% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.